Literature DB >> 12177369

Depressive symptoms, cognitive decline, and risk of AD in older persons.

Robert S Wilson1, L L Barnes, C F Mendes de Leon, N T Aggarwal, J S Schneider, J Bach, J Pilat, L A Beckett, S E Arnold, D A Evans, D A Bennett.   

Abstract

BACKGROUND: Cross-sectional and retrospective case-control studies suggest an association of depression symptoms with cognitive impairment and AD, but there have been few prospective studies and their results have been inconsistent.
METHODS: Participants are Catholic clergy members who were aged > or =65 years and who did not have clinical evidence of AD. During a 7-year period, they underwent annual clinical evaluations that included clinical classification of AD and detailed cognitive function testing from which global and specific measures of cognition were derived. Number of depressive symptoms was assessed at baseline with a modified, 10-item Center for Epidemiologic Studies Depression Scale (CES-D). The association of CES-D score with incident AD, using proportional hazards models, and cognitive decline, using random effects models, was examined.
RESULTS: At baseline, participants reported an average of about one depressive symptom on the CES-D scale (range, 0 to 8). During the 7 years of follow-up, 108 persons developed AD. In analyses that controlled for selected demographic and clinical variables including baseline level of cognitive function, CES-D score was associated with both risk of AD and rate of cognitive decline. For each depressive symptom, risk of developing AD increased by an average of 19%, and annual decline on a global cognitive measure increased by an average of 24%.
CONCLUSIONS: The results raise the possibility that depressive symptoms in older persons may be associated with risk of developing AD.

Entities:  

Mesh:

Year:  2002        PMID: 12177369     DOI: 10.1212/wnl.59.3.364

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  179 in total

1.  Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study.

Authors:  Jeannie-Marie S Leoutsakos; Sarah N Forrester; Christopher D Corcoran; Maria C Norton; Peter V Rabins; Martin I Steinberg; Joann T Tschanz; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2014-11-03       Impact factor: 3.485

2.  ACTIVE cognitive training and rates of incident dementia.

Authors:  Frederick W Unverzagt; Lin T Guey; Richard N Jones; Michael Marsiske; Jonathan W King; Virginia G Wadley; Michael Crowe; George W Rebok; Sharon L Tennstedt
Journal:  J Int Neuropsychol Soc       Date:  2012-03-09       Impact factor: 2.892

3.  The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia.

Authors:  E F J Meulen; B Schmand; J P van Campen; S J de Koning; R W Ponds; P Scheltens; F R Verhey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

4.  Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial.

Authors:  Davangere P Devanand; Gregory H Pelton; Kristina D'Antonio; Adam Ciarleglio; Jennifer Scodes; Howard Andrews; Julia Lunsford; John L Beyer; Jeffrey R Petrella; Joel Sneed; Michaela Ciovacco; Pudugramam Murali Doraiswamy
Journal:  Am J Geriatr Psychiatry       Date:  2018-06-28       Impact factor: 4.105

5.  Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder.

Authors:  Jeffrey N Motter; Gregory H Pelton; Kristina D'Antonio; Sara N Rushia; Monique A Pimontel; Jeffrey R Petrella; Ernst Garcon; Michaela W Ciovacco; Joel R Sneed; P Murali Doraiswamy; Davangere P Devanand
Journal:  Int J Geriatr Psychiatry       Date:  2018-07-23       Impact factor: 3.485

6.  Social engagement and cognitive function in old age.

Authors:  Kristin R Krueger; Robert S Wilson; Julia M Kamenetsky; Lisa L Barnes; Julia L Bienias; David A Bennett
Journal:  Exp Aging Res       Date:  2009 Jan-Mar       Impact factor: 1.645

7.  Non-cognitive psychopathological symptoms associated with incident mild cognitive impairment and dementia, Alzheimer's type.

Authors:  Antonio Lobo; Raúl López-Antón; Concepción de-la-Cámara; Miguel Angel Quintanilla; Antonio Campayo; Pedro Saz
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

8.  Ethnicity/culture modulates the relationships of the haptoglobin (Hp) 1-1 phenotype with cognitive function in older individuals with type 2 diabetes.

Authors:  Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Hadas Hoffman; Rachel Preiss; Keren Koifmann; Lior Greenbaum; Andrew Levy; Jeremy M Silverman; Derek Leroith; Mary Sano; Michal Schnaider-Beeri
Journal:  Int J Geriatr Psychiatry       Date:  2015-09-21       Impact factor: 3.485

9.  Elevation in plasma Abeta42 in geriatric depression: a pilot study.

Authors:  Nunzio Pomara; P Murali Doraiswamy; Lisa M Willoughby; Amy E Roth; Benoit H Mulsant; John J Sidtis; Pankaj D Mehta; Charles F Reynolds; Bruce G Pollock
Journal:  Neurochem Res       Date:  2006-04-01       Impact factor: 3.996

10.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.